SCHEMBL23213301

SCHEMBL23213301

Fc1ccc(OCc2ccccc2)c(C2CCN(C3COC4(C3)CN(c3nnco3)C4)CC2)c1.Fc1ccc(OCc2ccccc2)c(C2CCN(C3COC4(CNC4)C3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 7/20 0.47
CHRM1 P11229 7/20 0.47
SLC6A2 P23975 6/20 0.40
SLC6A4 P31645 6/20 0.40
SLC6A3 Q01959 6/20 0.40
HTR1A P08908 6/20 0.40
CHRM2 P08172 2/20 0.37
CHRM5 P08912 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.33
HTR6 P50406 1/20 0.32
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
HTR7 P34969 1/20 0.31
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23213891 0.96 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL29619684 0.96 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213887 0.96 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213543 0.91 CHRM4 (0.48) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL29619696 0.89 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213411 0.89 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213409 0.89 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213165 0.87 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23213162 0.87 CHRM4 (0.50) CHRM4CHRM1SLC6A2SLC6A4SLC6A3
SCHEMBL23230168 0.85 CHRM4 (0.40) CHRM4CHRM1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed